Notifiable infectious disease* | Average annual frequency | Average annual notification rate (range)/100,000 inhabitants | NRR 7(range) | |||||
---|---|---|---|---|---|---|---|---|
Total | ≥65 years | Total | <5 years | 5-19 years | 20-64 years | ≥65 years | 65+/20-64 | |
Overall | 15870 | 1792 | 332 (307–362) | 330 (285–407) | 330 (276–399) | 351 (312–411) | 253 (236–280) | 0.7 (0.6-0.9) |
Invasive bacterial diseases (IBD) | ||||||||
Pneumococcal IBD | 818 | 411 | 17.1 (14.9-20.4) | 13.0 (9.1-19.7) | 2.3 (1.2-3.1) | 12.1 (10.1-14.9) | 58.1 (51.6-66.4) | 4.8 (4.4-5.1) |
Group B Streptococcal IBD | 178 | 78 | 3.7 (3.4 -3.9) | 14.1 (12.3-15.9) | 0.2 (0.0-0.4) | 2.0 (1.8-2.2) | 11.0 (9.8-12.5) | 5.6 (4.5-7.6) |
Group A Streptococcal IBD | 163 | 68 | 3.4 (2.8-3.6) | 2.6 (1.0) | 0.7 (0.4-0.9) | 2.8 (2.1-3.2) | 9.5 (8.8-10.7) | 3.4 (2.7-4.5) |
Haemophilus influenzae IBD | 81 | 40 | 1.7 (1.5-1.8) | 2.2 (1.4-3.4) | 0.4 (0.2-0.5) | 1.1 (0.8-1.4) | 5.7 (4.4-7.0) | 5.6 (3.5-8.9) |
Meningococcal IBD | 37 | 5.8 | 0.8 (0.6-0.9) | 3.2 (2.3-4.1) | 1.3 (0.9-2.0) | 0.3 (0.3-0.4) | 0.8 (0.3-1.1) | 2.4 (1.0-3.6) |
Food- and waterborne diseases 1 | ||||||||
Campylobacteriosis | 2839 | 217 | 59.2 (55.0-60.9) | 62.4 (47.7-77.7) | 36.2 (31.1-41.6) | 73.4 (70.5-75.6) | 30.5 (25.1-38.3) | 0.4 (0.4-0.5) |
Salmonellosis | 1485 | 125 | 31.0 (26.0-40.8) | 48.2 (36.9-56.9) | 22.4 (18.1-30.0) | 35.3 (28.0-47.5) | 17.6 (12.3-21.8) | 0.5 (0.4-0.7) |
Listeriosis | 31 | 20 | 0.7 (0.4-1.0) | 0.3 (0.0-0.7) | 0.0 (0.0-0.0) | 0.4 (0.1-0.7) | 2.8 (2.3-4.2) | 15.6 (3.8-37.5) |
Enteropathogenic E. coli-enteritis 2 | 272 | 9.2 | 5.6 (2.3-9.3) | 61.1 (15.2-115.9) | 2.2 (0.8-3.2) | 2.0 (1.8-2.2) | 1.3 (0.4-2.2) | 0.6 (0.2-1.0) |
Giardiasis | 192 | 9.0 | 4.0 (3.6-5.0) | 7.9 (4.8-10.1) | 3.4 (2.8-3.7) | 4.5 (3.9-5.8) | 1.3 (0.8-1.9) | 0.3 (0.2-0.3) |
Shigellosis | 144 | 6.4 | 3.0 (2.7-3.3) | 3.7 (1.9-5.5) | 1.8 (1.4-2.4) | 3.8 (3.3-4.7) | 0.90 (0.3-1.4) | 0.2 (0.1-0.4) |
Paratyphoid fever | 16 | 1.0 | 0.3 (0.2-0.4) | 0.3 (0.0-0.7) | 0.3 (0.0-0.9) | 0.4 (0.2-0.5) | 0.1 (0.0-0.4) | 0.4 (0.0-1.1) |
Yersiniosis | 59 | 2.8 | 1.2 (1.1-1.5) | 3.4 (2.2-4.4) | 1.0 (0.7-1.3) | 1.3 (1.0-1.7) | 0.4 (0.0-0.7) | 0.3 (0. 0–0.6) |
Typhoid fever | 17 | 0.2 | 0.4 (0.2-0.6) | 0.6 (0.3-1.7) | 0.5 (0.4-0.5) | 0.4 (0.2-0.7) | 0.0 (0.0-0.1) | 0.0 (0.0-0.2) |
Vaccine preventable diseases | ||||||||
Pertussis | 4328 | 383 | 90.4 (66.3-115.5) | 56.3 (42.8-63.8) | 211.5 (162.0-277.6) | 63.4 (44.0-82.1) | 54.2 (34.8-70.4) | 0.9 (0.7-1.0) |
Mumps 3 | 16 | 1.4 | 0.3 (0.2-0.5) | 0.1 (0.0-0.6) | 0.3 (0.1-1.0) | 0.4 (0.3-0.5) | 0.2 (0.1-0.3) | 0.6 (0.3-1.0) |
Tetanus | 1.0 | 1.0 | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) | 0.1 (0.0-0.3) | ∞ (∞) |
Antibiotic-resistant bacteria | ||||||||
MRSA infection 3, 4 | 420 | 92 | 8.7 (7.3-11.4) | 11.0 (8.8-13.3) | 6.5 (5.1-9.4) | 8.2 (6.6-11.4) | 13 (11.4-16.1) | 1.6 (1.2-2.1) |
MRSA carriage 3, 4 | 384 | 82 | 8.0 (5.6-9.9) | 16.3 (8.6-21.4) | 4.6 (1.5-6.6) | 7.3 (4.9-9.2) | 12.2 (10.6-14.8) | 1.7 (1.2-2.7) |
Vancomycin-resistant enterococci 3 | 51 | 33 | 1.0 (0.1-4.3) | 0.1 (0.1-0.3) | 0.1 (0.0-0.4) | 0.6 (0.1-2.3) | 4.5 (0.6-19.4) | 6.5 (4.0-8.6) |
Penicillin-resistant pneumococci 3 | 11 | 1.4 | 0.2 (0.0-0.5) | 1.1 (0.0-3.5) | 0.1 (0.0-0.2) | 0.2 (0.0-0.4) | 0.2 (0.1-0.3) | 1.7 (0.4-4.0) |
Zoonosis/vector-borne diseases | ||||||||
Lyme borreliosis 3 | 297 | 57 | 6.2 (5.1-7.3) | 5.6 (4.6-6.2) | 8.9 (6.3-10.9) | 4.9 (3.6-6.4) | 8.1 (6.3-9.8) | 1.7 (1.5-1.9) |
Tularaemia | 66 | 10 | 1.4 (0.3-3.6) | 0.7 (0.0-2.3) | 1.0 (0.2-2.8) | 1.5 (0.3-3.9) | 1.4 (0.1-3.8) | 0.8 (0.4-1.0) |
HFRS 5/Nephropathia epidemica | 40 | 4.6 | 0.8 (0.4-1.6) | 0.1 (0.0-0.3) | 0.3 (0.1-0.6) | 1.2 (0.6-2.3) | 0.7 (0.3-1.2) | 0.7 (0.2-1.0) |
Malaria | 32 | 1.0 | 0.7 (0.6-0.8) | 0.2 (0.0-0.3) | 0.2 (0.1-0.3) | 1.0 (0.9-1.2) | 0.1 (0.0-0.4) | 0.1 (0.0-0.4) |
Blood-borne/STI | ||||||||
Hepatitis C 3, 6 | 2270 | 36 | 47.2 (33.7-70.5) | 2.3 (1.0-4.8) | 5.1 (4.0-7.0) | 76.1 (53.6-114.1) | 5.0 (4.6-5.8) | 0.1 (0.1-0.1) |
Hepatitis B (chronic carriage) | 693 | 13 | 14.4 (14.3-17.4) | 0.7 (0.0-1.4) | 8.5 (6.4-11.0) | 20.9 (15.7-24.9) | 1.8 (1.0-2.3) | 0.1 (0.1-0.1) |
Gonorrhoea | 266 | 4.2 | 5.5 (4.6-6.3) | 0.1 (0.0-0.3) | 1.4 (0.9-1.6) | 8.7 (7.4-9.8) | 0.6 (0.1-1.2) | 0.1 (0.0-0.1) |
Hepatitis A | 36 | 3.0 | 0.7 (0.4-1.0) | 1.1 (0.7-2.3) | 0.9 (0.6-1.4) | 0.7 (0.3-1.1) | 0.4 (0.1-1.0) | 0.6 (0.4-1.4) |
HIV infection | 256 | 2.6 | 5.3 (4.9-5.9) | 0.9 (0.0-2.1) | 0.6 (0.4-0.9) | 8.6 (8.0-9.5) | 0.4 (0.3-0.6) | 0.0 (0.0-0.1) |
AIDS | 33 | 2.2 | 0.7 (0.4-0.9) | 0.0 (0.0-0.0) | 0.0 (0.0-0.2) | 1.0 (0.6-1.4) | 0.3 (0.0-1.0) | 0.3 (0.0-1.0) |
Hepatitis B (acute infection) | 71 | 1.4 | 1.5 (0.6-2.6) | 0.1 (0.0-0.3) | 0.6 (0.1-1.3) | 2.2 (0.9-3.8) | 0.2 (0.0-0.4) | 0.1 (0.0-0.2) |
Syphilis | 88 | 0.8 | 1.8 (1.2-2.6) | 0.0 (0.0-0.0) | 0.1 (0.0-0.6) | 3.0 (1.9-4.4) | 0.1 (0.0-0.3) | 0.0 (0.0-0.1) |
Other diseases | ||||||||
Tuberculosis | 336 | 38 | 7.0 (6.5-7.5) | 1.5 (0.7-2.1) | 4.4 (3.5-4.6) | 8.8 (7.7-9.7) | 5.3 (4.5-6.9) | 0.6 (0.5-0.9) |
Encephalitis | 179 | 17 | 3.7 (2.8-6.4) | 8.8 (5.5-17.2) | 2.4 (1.4-4.9) | 3.9 (2.9-6.5) | 2.4 (1.9-3.2) | 0.6 (0.5-0.8) |
Legionellosis | 40 | 15 | 0.8 (0.7-1.0) | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) | 0.9 (0.7-1.1) | 2.1 (1.5-3.0) | 2.3 (1.8-3.2) |
Creutzfeldt Jacob 3 | 9.6 | 7.2 | 0.2 (0.1-0.3) | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) | 0.1 (0.0-0.1) | 1.0 (0.3-1.4) | 12.3 (2.0-∞) |